Bradykinin modulation of tumor vasculature: I. Activation ofB2 receptors increases delivery of chemotherapeuticagents into solid peripheral tumors, enhancing their efficacy

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 2, 2001, Pages 623-631

  Emerich, Dwaine F ^a   Snodgrass, Pamela ^a   Dean, Reginald L ^a   Lafreniere, Denise ^a   Agostino, Mary ^a   Wiens, Tania ^a   Xiong, Hua ^a   Hasler, Brant ^a   Marsh, Joanne ^a   Pink, Melissa ^a   Kim, Byong Su ^a   Bartus, Raymond T ^a  

^a ALKERMES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BRADYKININ B2 RECEPTOR AGONIST; CARBOPLATIN; CARMUSTINE; DEXTRAN; DOXORUBICIN; LOBRADIMIL; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CANCER SURVIVAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EFFICACY; DRUG TISSUE LEVEL; FEMALE; GROWTH INHIBITION; HYDROPHILICITY; LIPOPHILICITY; MALE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SOLID TUMOR; TUMOR GROWTH; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BRADYKININ; CELL SURVIVAL; FEMALE; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS, EXPERIMENTAL; LUNG NEOPLASMS; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RATS; RATS, INBRED F344; RATS, WISTAR; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; REGIONAL BLOOD FLOW; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0035141292     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The blood-brain barrier as a target for pharmacologicalmodulation
2. Controlled modulation of BBB permeability using thebradykinin agonist, RMP-7
3. Permeability of the BBB by the bradykinin agonist, RMP-7: Evidence for a sensitive, auto-regulated, receptor-mediated system
4. Intravenous Cereport (RMP-7) modifies topographic uptakeprofile of carboplatin within rat glioma and brain surroundingtumor, elevates platinum levels and enhances survival
5. Effects of bradykinin on the hemodynamics of tumor andgranulating normal tissue microvasculature
6. Intravenous RMP-7 selectively increases uptake ofcarboplatin into rat brain tumors
7. The development of the bradykipin agonist, Cereport (RMP-7),as a means to increase permeability of the blood-brain barrier: From concept to initial clinical indication
8. Enhanced uptake of carboplatin into brain tumors withintravenous Cereport (RMP-7): Dramatic differences as a function ofdosing parameters
9. Bradykinin modulation of tumor vasculature. II. Activationof nitric oxide and phospholipase A2/prostaglandin signalingpathways synergistically modify vascular physiology and morphologyto enhance delivery of chemotherapeutic agents to tumors
10. Intracarotid infusion of RMP-7, a bradykipin analog: Amethod for selective drug delivery to brain tumors
11. Transport of molecules across tumor vasculature
12. Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies
13. Vascular and interstitial barriers to delivery oftherapeutic agents in tumors
14. Haemodynamic and transport barriers to the treatment ofsolid tumors
15. B2 kinin receptor-mediated internalization of bradykinin inDDT1 MF-2 smooth muscle ce]]s is paralleled by sequestration of theoccupied receptors
16. In vivo and in vitro homologous desensitization of rat glomerular bradykipin B2 receptors
17. The influence of hydralazine on the vasculature, bloodperfusion and chemosensitivity of MAC tumours
18. Bradykinin receptors undergo ligand-induced desensitization
19. Pathway across blood-brain barrier opened by the bradykipinagonist, RMP-7
20. Genes expressed in human tumor endothelium
21. Chemical pathways of degradation of the bradykinin analog,RMP-7
22. Cyclic GMP-specific phosphodiesterase inhibition andintracarotid bradykipin infusion enhances permeability into braintumors
23. The mechanism for the rapid desensitization inbradykinin-stimulated inositol monophosphate production in NG108-15cells involves interaction of a single receptor with multiplesignaling pathways
24. Transvascular drug delivery in solid tumors